eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 15/08/2011
PIL Lamictal Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 06/12/2010 and displayed until 15/08/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 28/10/2010 and displayed until 06/12/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 13/07/2010 and displayed until 28/10/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 08/12/2009 and displayed until 13/07/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change due to user-testing of patient information
  • Changes to therapeutic indications
Updated on 05/03/2007 and displayed until 08/12/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change of manufacturer
Updated on 14/09/2006 and displayed until 05/03/2007
Reasons for adding or updating:
  • Change to drug interactions
  • Change to side-effects
Updated on 26/08/2005 and displayed until 14/09/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 18/03/2004 and displayed until 26/08/2005
Reasons for adding or updating:
  • Change of product licence name
Updated on 19/08/2003 and displayed until 18/03/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 25/05/2001 and displayed until 19/08/2003
Reasons for adding or updating:
  • No reasons supplied
Updated on 07/12/2000 and displayed until 25/05/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  lamotrigine